$52.48
N/A
Últ. Act.: Nov 4, 4:00 PM
MBX Biosciences (MBX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.62 | $-0.59 | $-0.61 | $-0.69 |
| Actual | $-0.78 | $-0.51 | $-0.49 | $-0.63 |
| Surprise | -25.8% | +13.6% | +19.7% | +8.70% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | — |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.84 | $-0.92 | $-0.74 | $-0.77 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.78 | $-0.62 | -25.8 % |
| Q1 | May 7, 2026 | $-0.51 | $-0.59 | 13.6 % |
| Q4 | Mar 12, 2026 | $-0.49 | $-0.61 | 19.7 % |
| Q3 | Nov 6, 2025 | $-0.63 | $-0.69 | 8.70 % |